Latest news with #MatthewHedberg
Yahoo
31-05-2025
- Business
- Yahoo
H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall
On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue shortfall in Q1 2025. Despite this, H.C. Wainwright believes that Invivyd is transitioning from a company solely focused on COVID-19 to a broader antibody-based infectious disease platform. A researcher examining a microscope in a laboratory to further their clinical-stage discovery. The firm also noted early signs of operational stabilization and pipeline expansion emerging in Q2 2025. Invivyd reported Q1 PEMGARDA net product revenue of $11.3 million, which was a decrease from $13.8 million sequentially. This decline was attributed to a planned transition from a contracted to an internalized sales force in January and February. However, the company has observed a re-acceleration of PEMGARDA revenue in Q2 2025 to date, with strong reported revenues, including record commercial days and weeks. Despite these positive signs, Invivyd faced a setback in February when the FDA declined its application for expanded Emergency Use Authorization/EUA of PEMGARDA to include treatment for active mild to moderate COVID-19 in immunocompromised individuals due to insufficient assurance of clinical benefit. Invivyd is now expanding its pipeline to include discovery programs against new viral targets, aiming to identify best-in-class medicines for diseases beyond COVID-19, such as RSV and measles. Invivyd Inc. (NASDAQ:IVVD) is a biopharmaceutical company that discovers, develops, and commercializes antibody-based solutions for infectious diseases in the US. While we acknowledge the potential of IVVD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IVVD and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
29-05-2025
- Business
- Yahoo
RBC Capital Lifts Informatica (INFA) PT to $25, Keeps Sector Perform Rating
On Wednesday, RBC Capital Markets analyst Matthew Hedberg raised the price target for Informatica Inc. (NYSE:INFA) to $25 from $22, while maintaining a Sector Perform rating. This adjustment follows the announcement that Informatica has entered into a definitive agreement to be acquired by Salesforce (NYSE:CRM) for $25 per share. This acquisition values Informatica at ~$8 billion in equity, excluding Salesforce's existing investment. A business executive in a modern office looking over reports detailing artificial intelligence. Hedberg noted that the portfolios of Informatica and Salesforce are complementary, which suggests the merger is likely to proceed without significant regulatory scrutiny. Informatica maintains impressive gross profit margins of 80.54% and operates with a moderate level of debt, factors that likely attracted Salesforce's interest. The transaction is anticipated to be finalized in Salesforce's FY2027, which corresponds to the calendar year 2026, pending the fulfillment of customary closing conditions, such as approval by Informatica shareholders. This acquisition will potentially enhance Salesforce's product offerings by leveraging Informatica's expertise in data integration software and services. Informatica Inc. (NYSE:INFA) develops an AI-powered platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at enterprise scale worldwide. While we acknowledge the potential of INFA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INFA and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-05-2025
- Business
- Yahoo
RBC Capital Lifts Informatica (INFA) PT to $25, Keeps Sector Perform Rating
On Wednesday, RBC Capital Markets analyst Matthew Hedberg raised the price target for Informatica Inc. (NYSE:INFA) to $25 from $22, while maintaining a Sector Perform rating. This adjustment follows the announcement that Informatica has entered into a definitive agreement to be acquired by Salesforce (NYSE:CRM) for $25 per share. This acquisition values Informatica at ~$8 billion in equity, excluding Salesforce's existing investment. A business executive in a modern office looking over reports detailing artificial intelligence. Hedberg noted that the portfolios of Informatica and Salesforce are complementary, which suggests the merger is likely to proceed without significant regulatory scrutiny. Informatica maintains impressive gross profit margins of 80.54% and operates with a moderate level of debt, factors that likely attracted Salesforce's interest. The transaction is anticipated to be finalized in Salesforce's FY2027, which corresponds to the calendar year 2026, pending the fulfillment of customary closing conditions, such as approval by Informatica shareholders. This acquisition will potentially enhance Salesforce's product offerings by leveraging Informatica's expertise in data integration software and services. Informatica Inc. (NYSE:INFA) develops an AI-powered platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at enterprise scale worldwide. While we acknowledge the potential of INFA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INFA and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
29-05-2025
- Business
- Yahoo
H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall
On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue shortfall in Q1 2025. Despite this, H.C. Wainwright believes that Invivyd is transitioning from a company solely focused on COVID-19 to a broader antibody-based infectious disease platform. A researcher examining a microscope in a laboratory to further their clinical-stage discovery. The firm also noted early signs of operational stabilization and pipeline expansion emerging in Q2 2025. Invivyd reported Q1 PEMGARDA net product revenue of $11.3 million, which was a decrease from $13.8 million sequentially. This decline was attributed to a planned transition from a contracted to an internalized sales force in January and February. However, the company has observed a re-acceleration of PEMGARDA revenue in Q2 2025 to date, with strong reported revenues, including record commercial days and weeks. Despite these positive signs, Invivyd faced a setback in February when the FDA declined its application for expanded Emergency Use Authorization/EUA of PEMGARDA to include treatment for active mild to moderate COVID-19 in immunocompromised individuals due to insufficient assurance of clinical benefit. Invivyd is now expanding its pipeline to include discovery programs against new viral targets, aiming to identify best-in-class medicines for diseases beyond COVID-19, such as RSV and measles. Invivyd Inc. (NASDAQ:IVVD) is a biopharmaceutical company that discovers, develops, and commercializes antibody-based solutions for infectious diseases in the US. While we acknowledge the potential of IVVD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IVVD and that has 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-05-2025
- Business
- Yahoo
Informatica (INFA) Rating in Focus After $8 Billion Salesforce Deal
We recently published a list of . In this article, we are going to take a look at where Informatica Inc. (NYSE:INFA) stands against other AI stocks that are on analyst's radar today. On May 27, RBC Capital's analyst Matthew Hedberg maintained their 'Sector Perform' rating on Informatica Inc. (NYSE:INFA) and raised its price target to $22.00 from the previous target of $19.00. Informatica is a leader in enterprise AI-powered cloud data management. Analyst Matthew Hedberg cited Friday's Bloomberg report of takeover interest by Salesforce (CRM), noting that Informatica could be an attractive asset given key fundamental drivers. This includes the ongoing growth in data, the ongoing cloud mix-shift, and potential GenAI tailwinds. A business executive in a modern office looking over reports detailing artificial intelligence. The very same day, the news of Salesforce and Informatica agreeing for the former to acquire the latter for approximately $8 billion in equity value was confirmed on the respective companies' newsrooms. The acquisition is expected to boost Salesforce's artificial intelligence capabilities and give access to Informatica's data management tools. 'Together, Salesforce and Informatica will create the most complete, agent-ready data platform in the industry. By uniting the power of Data Cloud, MuleSoft, and Tableau with Informatica's industry-leading, advanced data management capabilities, we will enable autonomous agents to deliver smarter, safer, and more scalable outcomes for every company, and significantly strengthen our position in the $150 billion-plus enterprise data market.' Overall, INFA ranks 10th on our list of AI stocks that are on analyst's radar today. While we acknowledge the potential of INFA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than INFA and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
